These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9294616)

  • 21. Cell-cycle progression is not essential for c-Myc to block differentiation.
    Ryan KM; Birnie GD
    Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z; Ge L; Wang M; Carr BI
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of IL-3 on promoter usage, attenuation and antisense transcription of the c-myc oncogene in the IL-3-dependent Ba/F3 early pre-B cell line.
    Chang Y; Spicer DB; Sonenshein GE
    Oncogene; 1991 Nov; 6(11):1979-82. PubMed ID: 1682864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WI-38 cell long-term quiescence model system: a valuable tool to study molecular events that regulate growth.
    Soprano KJ
    J Cell Biochem; 1994 Apr; 54(4):405-14. PubMed ID: 8014189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
    Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor and c-Myc transcription factors as putative partners in the in vivo cross-talk between androgen receptor-mediated and c-Met-mediated signalling pathways.
    Dudkowska M; Jaworski T; Grzelakowska-Sztabert B; Manteuffel-Cymborowska M
    Acta Biochim Pol; 2007; 54(2):253-9. PubMed ID: 17520086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-modulation of c-myc expression by phorbol ester protects CEM T leukaemia cells from starvation-induced apoptosis: role of ornithine decarboxylase and polyamines.
    Tiberio L; Maier JA; Schiaffonati L
    Cell Death Differ; 2001 Oct; 8(10):967-76. PubMed ID: 11598794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JAK pathway induction of c-Myc critical to IL-5 stimulation of cell proliferation and inhibition of apoptosis.
    Lee WH; Liu FH; Lin JY; Huang SY; Lin H; Liao WJ; Huang HM
    J Cell Biochem; 2009 Apr; 106(5):929-36. PubMed ID: 19180571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large induction of c-Myc is not essential for the mitogenic response of Swiss 3T3 fibroblasts.
    Mehmet H; Littlewood TD; Sinnett-Smith J; Moore JP; Evan GI; Rozengurt E
    Cell Growth Differ; 1997 Feb; 8(2):187-93. PubMed ID: 9040940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of ornithine decarboxylase activity by IL-2 and cyclic AMP.
    Farrar WL; Vinocour M; Cleveland JL; Harel-Bellan A
    J Immunol; 1988 Aug; 141(3):967-71. PubMed ID: 2840461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid expression of ornithine decarboxylase mRNA in a macrophage-like cell line: cAMP repression of the requirement for prior protein synthesis.
    Shurtleff SA; McElwain CM; Taffet SM
    J Cell Physiol; 1988 Mar; 134(3):453-9. PubMed ID: 2832424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
    J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-1 induces ornithine decarboxylase in normal T lymphocytes.
    Bristol LA; Smith MR; Bhat NK; Durum SK
    J Immunol; 1991 Mar; 146(5):1509-15. PubMed ID: 1993840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct activation of TERT transcription by c-MYC.
    Wu KJ; Grandori C; Amacker M; Simon-Vermot N; Polack A; Lingner J; Dalla-Favera R
    Nat Genet; 1999 Feb; 21(2):220-4. PubMed ID: 9988278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic dissection of c-myc apoptotic pathways.
    Nesbit CE; Tersak JM; Grove LE; Drzal A; Choi H; Prochownik EV
    Oncogene; 2000 Jun; 19(28):3200-12. PubMed ID: 10918575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The proto-oncogene c-myc blocks myeloid differentiation independently of its target gene ornithine decarboxylase.
    Selvakumaran M; Liebermann D; Hoffman B
    Blood; 1996 Aug; 88(4):1248-55. PubMed ID: 8695842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.